Anti-Human VHL Monoclonal Antibody (1A521)

Anti-Human VHL Monoclonal Antibody (1A521)

The perfect solution for your biotech research needs.

This highly specific and potent antibody targets the human VHL (Von Hippel-Lindau) protein, a key player in cellular pathways involved in tumor growth and angiogenesis. By binding to VHL, this antibody effectively inhibits its function, making it an essential tool for studying VHL-related diseases and potential therapeutic interventions.

The main application of our Anti-Human VHL Monoclonal Antibody is in cancer research. VHL is known to play a crucial role in the development of various cancers, including clear cell renal cell carcinoma and hemangioblastoma. With our antibody, researchers can gain a better understanding of the mechanisms behind these diseases and potentially identify new targets for treatment.

But the potential of this antibody goes beyond cancer research. It has also been shown to be useful in studying other conditions such as polycythemia and pheochromocytoma, where VHL mutations have been implicated. By providing a specific and reliable tool, our antibody allows for more accurate and insightful research in these areas.

In addition to its main applications, our Anti-Human VHL Monoclonal Antibody has also been used in various experimental settings. It has been successfully used in Western blotting, immunoprecipitation, and immunofluorescence assays, demonstrating its versatility and reliability in different techniques.

With its high specificity and potency, our Anti-Human VHL Monoclonal Antibody (1A521) is a valuable addition to any biotech laboratory. Its targeted action and proven effectiveness make it an essential tool for studying VHL-related diseases and potential treatments. Don’t miss the opportunity to enhance your research with this powerful antibody. Order now and take your studies to the next level.